Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study.

Lerolle N, Laanani M, Galicier L, Rivière S, Meynard JL, Azoulay E, Jeblaoui A, Lalande V, Mougari F, Fardet L, Coppo P, Goujard C, Molina JM, Lambotte O.

Int J Tuberc Lung Dis. 2020 Jan 1;24(1):124-130. doi: 10.5588/ijtld.19.0856.

PMID:
32005316
2.

[Association between psychiatric comorbidities and hospital length of stay in post-emergency internal medicine patients].

Lampros A, Montardi C, Journeau L, Georgin-Lavialle S, Hanslik T, Dhôte R, Goujard C, Le Jeunne C, Mahe I, Papo T, Godeau B, Bourgarit A, Fain O, Fantin B, Dzierzynski N, Leblanc J, Nevoret C, Steichen O.

Rev Med Interne. 2020 Jan 22. pii: S0248-8663(20)30004-7. doi: 10.1016/j.revmed.2019.12.016. [Epub ahead of print] French.

PMID:
31982256
3.

Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.

Abgrall S, Raho-Moussa M, Seng R, Ghislain M, Matheron S, Pialoux G, Goujard C, Meyer L; ANRS CO9-COPANA study group†.

Antivir Ther. 2019;24(7):541-552. doi: 10.3851/IMP3339.

PMID:
31868654
4.

[Télédent, an oral tele-expertise experience in a penitentiary environment].

Novais A, Fac C, Allouche M, Atallah É, Godkine N, Guyader T, Hariga A, Hoarau W, Oulmi A, Trumbic F, Goujard C, Pirnay P.

Med Sci (Paris). 2019 Nov;35(11):866-870. doi: 10.1051/medsci/2019168. Epub 2019 Dec 17. French.

PMID:
31845878
5.

[Cervical spinal sarcoidosis mimicking compressive cervical myelopathy: Poor prognosis after surgery].

Urbain F, Labeyrie C, Herbrecht A, Nasser G, Cauquil C, Adam C, Lambotte O, Goujard C, Adams D, Noel N.

Rev Med Interne. 2020 Feb;41(2):78-88. doi: 10.1016/j.revmed.2019.11.006. Epub 2019 Dec 10. French.

PMID:
31836247
6.

Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV.

Besson C, Noel N, Lancar R, Prevot S, Algarte-Genin M, Rosenthal E, Bonnet F, Meyohas MC, Partisani M, Oberic L, Gabarre J, Goujard C, Cheret A, Arvieux C, Katlama C, Salmon D, Boué F, Costello R, Hendel-Chavez H, Taoufik Y, Fontaine H, Coppo P, Mounier N, Delobel P, Costagliola D; Lymphovir and FHDH study groups.

AIDS. 2020 Mar 15;34(4):599-608. doi: 10.1097/QAD.0000000000002461.

PMID:
31833850
7.

Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection.

Coindre S, Tchitchek N, Alaoui L, Vaslin B, Bourgeois C, Goujard C, Lecuroux C, Bruhns P, Le Grand R, Beignon AS, Lambotte O, Favier B.

Front Immunol. 2019 Nov 22;10:2677. doi: 10.3389/fimmu.2019.02677. eCollection 2019.

8.

Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection.

Veil R, Poizot-Martin I, Reynes J, Goujard C, Seng R, Delobel P, Cotte L, Duvivier C, Rey D, Tran L, Surgers L, Allavena C, Lascoux Combe C, Cheret A, Meyer L.

AIDS. 2020 Mar 15;34(4):493-500. doi: 10.1097/QAD.0000000000002447.

PMID:
31764069
9.

What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study.

Fiorentino M, Protière C, Sagaon-Teyssier L, Mimi M, Fressard L, Arnold MP, Lambotte O, Barbot J, Fainzang S, Meyer L, Goujard C, Préau M, Spire B, Suzan-Monti M.

J Virus Erad. 2019 Sep 18;5(3):152-162.

PMID:
31700662
10.

What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study.

Fiorentino M, Protière C, Sagaon-Teyssier L, Mimi M, Fressard L, Arnold MP, Lambotte O, Barbot J, Fainzang S, Meyer L, Goujard C, Préau M, Spire B, Suzan-Monti M.

J Virus Erad. 2019 Sep 18;5(3):152-162.

PMID:
31700661
11.

The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.

Henriquez S, Lécuroux C, Bitu M, Avettand-Fenoel V, Churaqui F, Catalan P, Chéret A, Boufassa F, Saez-Cirion A, Monceaux V, Meyer L, Goujard C, Lambotte O, Bourgeois C; ANRS CO6 PRIMO, the ANRS CO21 CODEX cohorts.

AIDS. 2019 Nov 15;33(14):2137-2147. doi: 10.1097/QAD.0000000000002342.

PMID:
31688039
12.

Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial.

Alejos B, Stella-Ascariz N, Montejano R, Rodriguez-Centeno J, Schwimmer C, Bernardino JI, Rodes B, Esser S, Goujard C, Sarmento-Castro R, De Miguel R, Esteban-Cantos A, Wallet C, Raffi F, Arribas JR; NEAT 001/ANRS 143 Study Group.

HIV Med. 2019 Nov;20(10):691-698. doi: 10.1111/hiv.12791. Epub 2019 Sep 18.

PMID:
31532902
13.

The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients.

Henriquez S, Lecuroux C, Bitu M, Avettand-Fenoel V, Churaqui F, Catalan P, Cheret A, Boufassa F, Saez-Cirion A, Monceaux V, Meyer L, Goujard C, Lambotte O, Bourgeois C; ANRS CO6 PRIMO, the ANRS CO21 CODEX cohorts.

AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002342. [Epub ahead of print]

PMID:
31385864
14.

Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1-Infected Patients with Central Nervous System Impairment.

Gelé T, Furlan V, Taburet AM, Pallier C, Becker PH, Goujard C, Gasnault J, Barrail-Tran A, Chéret A.

Open Forum Infect Dis. 2019 Jun 3;6(6):ofz174. doi: 10.1093/ofid/ofz174. eCollection 2019 Jun.

15.

18F-FDG PET/CT of sarcoidosis with extensive cutaneous and subcutaneous nodules: the snow leopard sign.

Bompard F, de Menthon M, Gomez L, Gottlieb J, Saleh NS, Chekroun M, Grimon G, Goujard C, Durand E, Besson FL.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1980-1981. doi: 10.1007/s00259-019-04353-0. Epub 2019 May 24. No abstract available.

PMID:
31123764
16.

In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and Quebec.

Chaillon A, Delaugerre C, Brenner B, Armero A, Capitant C, Nere ML, Leturque N, Pialoux G, Cua E, Tremblay C, Smith DM, Goujard C, Meyer L, Molina JM, Chaix ML.

Open Forum Infect Dis. 2019 Feb 15;6(3):ofz080. doi: 10.1093/ofid/ofz080. eCollection 2019 Mar.

17.

Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection.

Trémeaux P, Lenfant T, Boufassa F, Essat A, Mélard A, Gousset M, Delelis O, Viard JP, Bary M, Goujard C, Rouzioux C, Meyer L, Avettand-Fenoel V; ANRS-SEROCO and PRIMO cohorts.

EBioMedicine. 2019 Mar;41:455-464. doi: 10.1016/j.ebiom.2019.02.016. Epub 2019 Feb 23.

18.

Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants.

Delagreverie HM, Grude M, Lambert-Niclot S, Nere ML, Jadand C, Leport C, Raffi F, Ghislain M, Goujard C, Meyer L, Calvez V, Katlama C, Flandre P, Barin F, Delaugerre C.

J Antimicrob Chemother. 2019 May 1;74(5):1389-1394. doi: 10.1093/jac/dkz004.

PMID:
30690509
19.

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.

Shili-Masmoudi S, Sogni P, de Ledinghen V, Esterle L, Valantin MA, Poizot-Martin I, Simon A, Rosenthal E, Lacombe K, Pialoux G, Bouchaud O, Gervais-Hasenknoff A, Goujard C, Piroth L, Zucman D, Dominguez S, Raffi F, Alric L, Bani-Sadr F, Lascoux-Combe C, Garipuy D, Miailhes P, Vittecoq D, Duvivier C, Aumaître H, Neau D, Morlat P, Dabis F, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group.

PLoS One. 2019 Jan 25;14(1):e0211286. doi: 10.1371/journal.pone.0211286. eCollection 2019.

20.

Perceived HIV-related physical fatigue, sociodemographic characteristics and physical activity: A cross-sectional study.

Bergamaschi A, d'Arripe-Longueville F, Gray LL, Colson SS, Goujard C, Ferez S, Rouanet I, Durant J, Rosenthal E, Pradier C, Duracinsky M, Schuft L.

J Clin Nurs. 2019 Jun;28(11-12):2147-2156. doi: 10.1111/jocn.14793. Epub 2019 Mar 3.

PMID:
30667107
21.

Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.

Bouvin-Pley M, Beretta M, Moreau A, Roch E, Essat A, Goujard C, Chaix ML, Moiré N, Martin L, Meyer L, Barin F, Braibant M.

J Virol. 2019 Mar 5;93(6). pii: e01171-18. doi: 10.1128/JVI.01171-18. Print 2019 Mar 15.

22.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.

Billa O, Chalouni M, Salmon D, Poizot-Martin I, Gilbert C, Katlama C, Neau D, Chas J, Morlat P, Lacombe K, Naqvi A, Barange K, Gervais A, Bouchaud O, Rosenthal E, Lascoux-Combe C, Garipuy D, Alric L, Dominguez S, Vittecoq D, Goujard C, Duvivier C, Aumaitre H, Miailhes P, Zucman D, Simon A, Lazaro E, Raffi F, Esterle L, Wittkop L, Bani-Sadr F; ANRS CO13 HEPAVIH Study Group.

PLoS One. 2018 Dec 18;13(12):e0208657. doi: 10.1371/journal.pone.0208657. eCollection 2018.

23.

Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.

Stefic K, Bouvin-Pley M, Essat A, Visdeloup C, Moreau A, Goujard C, Chaix ML, Braibant M, Meyer L, Barin F.

J Virol. 2019 Jan 4;93(2). pii: e01492-18. doi: 10.1128/JVI.01492-18. Print 2019 Jan 15.

24.

Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.

Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lachâtre M, Choisy P, Ajana F, Bourdic K, Viget N, Riff B, Quertainmont Y, Cortet B, Boufassa F, Chéret A.

AIDS. 2018 Nov 28;32(18):2689-2696. doi: 10.1097/QAD.0000000000002001.

PMID:
30234605
25.

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens.

Potard V, Goujard C, Valantin MA, Lacombe JM, Lahoulou R, Chéret A, Girard PM, Costagliola D; French Hospital Database on HIV (FHDH - ANRS CO4).

BMC Infect Dis. 2018 Jul 11;18(1):326. doi: 10.1186/s12879-018-3231-5.

26.

Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.

Ploquin MJ, Casrouge A, Madec Y, Noël N, Jacquelin B, Huot N, Duffy D, Jochems SP, Micci L, Lécuroux C, Boufassa F, Booiman T, Garcia-Tellez T, Ghislain M, Grand RL, Lambotte O, Kootstra N, Meyer L, Goujard C, Paiardini M, Albert ML, Müller-Trutwin M.

J Int AIDS Soc. 2018 Jul;21(7):e25144. doi: 10.1002/jia2.25144.

27.

Motivational interviewing training for medical students: A pilot pre-post feasibility study.

Chéret A, Durier C, Noël N, Bourdic K, Legrand C, D'Andréa C, Hem E, Goujard C, Berthiaume P, Consoli SM.

Patient Educ Couns. 2018 Nov;101(11):1934-1941. doi: 10.1016/j.pec.2018.06.011. Epub 2018 Jun 21.

PMID:
29958765
28.

Calendar trends in sexual behaviours in a cohort of HIV-infected MSM at the era of treatment as prevention of HIV infection.

Champenois K, Seng R, Persoz A, Essat A, Gaud C, Laureillard D, Robineau O, Duvivier C, Yazdanpanah Y, Goujard C, Meyer L; ANRS PRIMO cohort study group.

AIDS. 2018 Aug 24;32(13):1871-1879. doi: 10.1097/QAD.0000000000001916.

PMID:
29927787
29.

Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.

Beretta M, Moreau A, Bouvin-Pley M, Essat A, Goujard C, Chaix ML, Hue S, Meyer L, Barin F, Braibant M; ANRS 06 Primo Cohort.

AIDS. 2018 Sep 10;32(14):1917-1926. doi: 10.1097/QAD.0000000000001906.

30.

Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a+ CD4+ T Cells From Early HIV Infection to Effective cART.

Coindre S, Tchitchek N, Alaoui L, Vaslin B, Bourgeois C, Goujard C, Avettand-Fenoel V, Lecuroux C, Bruhns P, Le Grand R, Beignon AS, Lambotte O, Favier B; ANRS CO6 PRIMO Cohort.

Front Immunol. 2018 Jun 4;9:1217. doi: 10.3389/fimmu.2018.01217. eCollection 2018.

31.

Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.

Néel A, Wahbi A, Tessoulin B, Boileau J, Carpentier D, Decaux O, Fardet L, Geri G, Godmer P, Goujard C, Maisonneuve H, Mari A, Pouchot J, Ziza JM, Bretonnière C, Hamidou M.

Crit Care. 2018 Apr 11;22(1):88. doi: 10.1186/s13054-018-2012-2.

32.

Interferon-associated therapies toward HIV control: The back and forth.

Noël N, Jacquelin B, Huot N, Goujard C, Lambotte O, Müller-Trutwin M.

Cytokine Growth Factor Rev. 2018 Apr;40:99-112. doi: 10.1016/j.cytogfr.2018.03.004. Epub 2018 Mar 9. Review.

33.

Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC).

Preau M, Doumergue M, Protiere C, Goujard C, Mora M, Meyer L, Lelievre JD, Raffi F, Spire B, Lambotte O, Suzan-Monti M.

AIDS Care. 2018 Jul;30(7):914-920. doi: 10.1080/09540121.2018.1426825. Epub 2018 Jan 18.

PMID:
29347826
34.

Hospitalization of HIV positive patients: Significant demand affecting all hospital sectors.

Seng R, Mutuon P, Riou J, Duvivier C, Weiss L, Lelievre JD, Meyer L, Vittecoq D, Zak Dit Zbar O, Frenkiel J, Frank-Soltysiak M, Boue F, Rapp C, Sobel A, Brucker G, Goujard C, Salmon D; COREVIH.

Rev Epidemiol Sante Publique. 2018 Feb;66(1):7-17. doi: 10.1016/j.respe.2017.08.002. Epub 2017 Dec 10.

PMID:
29233572
35.

Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection.

Novelli S, Lécuroux C, Avettand-Fenoel V, Seng R, Essat A, Morlat P, Viard JP, Rouzioux C, Meyer L, Goujard C.

Clin Infect Dis. 2018 May 2;66(10):1519-1527. doi: 10.1093/cid/cix1068.

PMID:
29211834
36.

Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.

Alaoui L, Palomino G, Zurawski S, Zurawski G, Coindre S, Dereuddre-Bosquet N, Lecuroux C, Goujard C, Vaslin B, Bourgeois C, Roques P, Le Grand R, Lambotte O, Favier B.

Cell Mol Life Sci. 2018 May;75(10):1871-1887. doi: 10.1007/s00018-017-2712-9. Epub 2017 Nov 13.

PMID:
29134249
37.

Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).

Protière C, Spire B, Mora M, Poizot-Martin I, Préau M, Doumergue M, Morlat P, Zucman D, Goujard C, Raffi F, Lambotte O, Suzan-Monti M.

PLoS One. 2017 Nov 2;12(11):e0187489. doi: 10.1371/journal.pone.0187489. eCollection 2017.

38.

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.

Besson C, Lancar R, Prevot S, Algarte-Genin M, Delobel P, Bonnet F, Meyohas MC, Partisani M, Oberic L, Gabarre J, Goujard C, Boue F, Coppo P, Costello R, Hendel-Chavez H, Mekerri N, Dos Santos G, Recher C, Delarue R, Casasnovas RO, Taoufik Y, Mounier N, Costagliola D; ANRS-CO16 LYMPHOVIR Cohort.

AIDS. 2017 Nov 28;31(18):2493-2501. doi: 10.1097/QAD.0000000000001652.

PMID:
28926410
39.

Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from an ongoing prospective cohort.

Boccara F, Ghislain M, Meyer L, Goujard C, Le May C, Vigouroux C, Bastard JP, Fellahi S, Capeau J, Cohen A, Cariou B; ANRS-COPANA Study Group.

AIDS. 2017 Nov 13;31(17):2367-2376. doi: 10.1097/QAD.0000000000001633.

40.

Effect of CRP value on 18F-FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis.

Gomez L, Chaumet-Riffaud P, Noel N, Lambotte O, Goujard C, Durand E, Besson FL.

Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):575-581. doi: 10.1007/s00259-017-3798-x. Epub 2017 Aug 30.

PMID:
28856429
41.

NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147.

Gondois-Rey F, Chéret A, Granjeaud S, Mallet F, Bidaut G, Lécuroux C, Ploquin M, Müller-Trutwin M, Rouzioux C, Avettand-Fenoël V, Moretta A, Pialoux G, Goujard C, Meyer L, Olive D.

Clin Transl Immunology. 2017 Jul 7;6(7):e150. doi: 10.1038/cti.2017.22. eCollection 2017 Jul.

42.

Impact of early cART on HIV blood and semen compartments at the time of primary infection.

Chéret A, Durier C, Mélard A, Ploquin M, Heitzmann J, Lécuroux C, Avettand-Fenoël V, David L, Pialoux G, Chennebault JM, Müller-Trutwin M, Goujard C, Rouzioux C, Meyer L; ANRS OPTIPRIM study group.

PLoS One. 2017 Jul 14;12(7):e0180191. doi: 10.1371/journal.pone.0180191. eCollection 2017.

43.

Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.

Seng R, Ghislain M, Girard PM, Cotte L, Meybeck A, Raffi F, Abgrall S, Yazdanpanah Y, Goujard C, Dray-Spira R, Meyer L.

AIDS. 2017 Jun 1;31(9):1323-1332. doi: 10.1097/QAD.0000000000001482.

PMID:
28492394
44.

Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).

Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salmon-Ceron D, Spire B, Roux P, Carrieri MP; ANRS CO13-HEPAVIH Study Group.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):786-791. doi: 10.1097/MEG.0000000000000883.

PMID:
28418984
45.

Cessation of oral anticoagulants in antiphospholipid syndrome.

Comarmond C, Jego P, Veyssier-Belot C, Marie I, Mekinian A, Elmaleh-Sachs A, Leroux G, Saadoun D, Oziol E, Fraisse T, Hyvernat H, Thiercein-Legrand MF, Sarrot-Reynauld F, Ferreira-Maldent N, de Menthon M, Goujard C, Khau D, Nguen Y, Monnier S, Michon A, Castel B, Decaux O, Piette JC, Cacoub P.

Lupus. 2017 Oct;26(12):1291-1296. doi: 10.1177/0961203317699285. Epub 2017 Mar 29.

PMID:
28355985
46.

Budget impact of antiretroviral therapy in a French clinic cohort.

Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y; ANRS-GOTA Study Group.

AIDS. 2017 Jun 1;31(9):1271-1279. doi: 10.1097/QAD.0000000000001467.

PMID:
28323753
47.

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART.

Gondois-Rey F, Chéret A, Mallet F, Bidaut G, Granjeaud S, Lécuroux C, Ploquin M, Müller-Trutwin M, Rouzioux C, Avettand-Fenoël V, De Maria A, Pialoux G, Goujard C, Meyer L, Olive D.

Front Immunol. 2017 Feb 10;8:54. doi: 10.3389/fimmu.2017.00054. eCollection 2017.

48.

Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies.

Chaillon A, Essat A, Frange P, Smith DM, Delaugerre C, Barin F, Ghosn J, Pialoux G, Robineau O, Rouzioux C, Goujard C, Meyer L, Chaix ML; on behalf the ANRS PRIMO Cohort Study.

Retrovirology. 2017 Feb 21;14(1):15. doi: 10.1186/s12977-017-0339-4.

49.

Recurrent obstructive acute pyelonephritis: A rare form of Actinotignum (Actinobaculum) schaalii infection in a HIV-1 infected patient.

Vallet A, Noël N, Bahi R, Teicher E, Quertainmont Y, Delfraissy JF, Ferlicot S, Potron A, Goujard C, Lambotte O.

Anaerobe. 2017 Feb;43:75-77. doi: 10.1016/j.anaerobe.2016.12.004. Epub 2016 Dec 8.

PMID:
27940245
50.

Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.

Ploquin MJ, Madec Y, Casrouge A, Huot N, Passaes C, Lécuroux C, Essat A, Boufassa F, Jacquelin B, Jochems SP, Petitjean G, Angin M, Gärtner K, Garcia-Tellez T, Noël N, Booiman T, Boeser-Nunnink BD, Roques P, Saez-Cirion A, Vaslin B, Dereudre-Bosquet N, Barré-Sinoussi F, Ghislain M, Rouzioux C, Lambotte O, Albert ML, Goujard C, Kootstra N, Meyer L, Müller-Trutwin MC.

PLoS Pathog. 2016 Aug 10;12(8):e1005774. doi: 10.1371/journal.ppat.1005774. eCollection 2016 Aug.

Supplemental Content

Loading ...
Support Center